Thomas Charles Heineman
Chief Medical Officer, Oncolytics Biotech.
Companies
- Oncolytics BiotechChief Medical Officer Jan 2, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Oncolytics Biotech ONCY282,818 shares2$142.0K at $0.50Feb 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 12, 2026Bought 12,132 shares at $0.83 of Oncolytics Biotech2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2